The effects of MTL longitudinal atrophy were mostly driven by A+T+ CU individuals (Table 2 and Figure 2), supporting the prognostic value of the amyloid/tau/neurodegeneration framework40 and more recent AD staging system in preclinical population (aaic.alz.org/diagnostic‐criteria.asp).7 Here, MAPT is linked to Alzheimer disease.